Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Differential Diagnosis for Bullous/Vesicular Rash in Neonates

Primary Differential Considerations

  • The Centers for Disease Control and Prevention recommends that neonatal herpes simplex virus infection remains the most critical diagnosis to consider, as vesicular rash is present in only approximately 60% of neonates with CNS or disseminated disease, and skin-limited HSV can occur without CNS involvement 1
  • Localized skin, eye, and mouth disease accounts for approximately 40% of neonatal HSV cases and typically presents at 10-11 days of age with vesicular lesions, according to the Centers for Disease Control and Prevention 1, 2
  • The distribution involving fingertips, glans penis, abdomen, and pubic region is consistent with HSV, which can affect any skin surface, as reported by Eurosurveillance 3, 4
  • A negative CSF HSV PCR does not exclude cutaneous HSV disease, as only 60% of neonates with skin disease have CNS involvement, according to the Centers for Disease Control and Prevention 1
  • Vesicles contain clear fluid with infectious viral particles that burst and form shallow ulcers with desquamation, matching this presentation, as described by Eurosurveillance 4
  • The Centers for Disease Control and Prevention recommends obtaining cultures from skin vesicles, blood, mouth/nasopharynx, eyes, urine, and stool/rectum to confirm diagnosis 1, 5
  • Direct immunofluorescence from lesion scrapings can provide rapid diagnosis, according to the Centers for Disease Control and Prevention 1

Diagnostic Algorithm

  • The Centers for Disease Control and Prevention recommends immediate HSV testing, including obtaining viral cultures from vesicle fluid, blood, mouth, eyes, urine, and stool, as well as direct immunofluorescence from lesion scrapings for rapid results 1, 5
  • Even with negative CSF, skin-limited HSV requires 14 days of IV acyclovir at 20 mg/kg/dose three times daily, as recommended by the Centers for Disease Control and Prevention 1, 5

Critical Management Points

  • Empiric IV acyclovir should be strongly considered while awaiting culture results given the catastrophic consequences of untreated neonatal HSV, according to the Centers for Disease Control and Prevention 1, 5
  • Neonates with skin lesions may have cutaneous recurrences during the first 6 months even after successful treatment, as reported by the Centers for Disease Control and Prevention 1, 5
  • Positive cultures from skin, mouth, eyes, urine, or stool obtained >48 hours after birth indicate viral replication rather than intrapartum contamination, according to the Centers for Disease Control and Prevention 1